Trials / Completed
CompletedNCT05091476
OcuDyne System in the Treatment of AMD
A Clinical Study to Evaluate the Safety and Feasibility of the OcuDyne System in the Treatment of Age-Related Macular Degeneration (AMD)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- OcuDyne, Inc. · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
Feasibility of the OcuDyne OPTiC System in patients with late-stage non-exudative age-related macular degeneration.
Detailed description
This study evaluates the safety and feasibility of using the OcuDyne OPTiC System in patients with late-stage non-exudative age-related macular degeneration.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | OPTiC System | OPTiC System procedure |
Timeline
- Start date
- 2023-02-27
- Primary completion
- 2024-07-31
- Completion
- 2024-10-01
- First posted
- 2021-10-25
- Last updated
- 2025-02-13
Locations
2 sites across 1 country: Argentina
Source: ClinicalTrials.gov record NCT05091476. Inclusion in this directory is not an endorsement.